Clinical trial

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC…

NCT00314626 · Germans Trias i Pujol Hospital, Other · Completed

Key facts

NCT number NCT00314626
Title Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Official title Multicentre, Open Label, Prospective, Randomised Clinical Trial of an Antiretroviral Simplification Treatment With Efavirenz + Abacavir + 3TC Once Daily
Lead sponsor Germans Trias i Pujol Hospital, Other
Collaborators Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Status Completed
Phase Phase 3
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions efavirenz, Abacavir+lamivudine
Enrollment 99
Start date Nov 1, 2004
Primary completion Feb 1, 2007
Completion Mar 1, 2007
First posted Apr 14, 2006
Last update posted Jan 29, 2008
Countries Spain

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies